Surrogate markers of antiangiogenic therapy in patients with locally advanced breast cancer with lymphangitic spread to the chest wall: Results from a phase II randomized study of bevacizumab with sequential versus concurrent oral vinorelbine plus capecitabine / M. Locatelli, G.C.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 26:15_suppl(2008), pp. 14649.1-14649.1. (ASCO Annual Meeting 2008) [10.1200/JCO.2008.26.15_SUPPL.14649].
Surrogate markers of antiangiogenic therapy in patients with locally advanced breast cancer with lymphangitic spread to the chest wall: Results from a phase II randomized study of bevacizumab with sequential versus concurrent oral vinorelbine plus capecitabine
G. Curigliano;S. Dellapasqua;
2008
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
